John Isaacs

Professor John Isaacs is a leading researcher at Newcastle University specializing in rheumatoid arthritis and autoimmune disease mechanisms. With a focus on biomarker discovery, therapeutic tolerance, and clinical trial design, his work bridges immunology, genomics, and translational medicine.

• Key Research Areas:
  • Immunobiology of rheumatoid arthritis
  • Anti-TNF therapy response prediction
  • Tolerogenic dendritic cell therapies
  • Genetic susceptibility in autoimmune diseases
  • Clinical trial methodology (e.g., DEFINE/SPIRIT-DEFINE)
  • Interferon signaling in disease progression
• Clinical Contributions:
  • Principal investigator in BIO-FLARE and APIPPRA trials
  • Leadership in EULAR guidelines for therapeutic drug monitoring
  • Analysis of drug-free remission predictors
  • Advocacy for ultrasound and genomic biomarkers in RA

Collaborations span academia-industry partnerships like the RA-MAP Consortium, with extensive publications on T cell immunology, cytokine signaling, and precision medicine in inflammatory diseases.